Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
SZSE:300357.SZ
26.98 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 848.19 | 896.016 | 807.692 | 636.208 | 639.353 | 500.745 | 385.577 | 312.086 | 267.106 | 239.511 | 193.61 | 147.517 | 103.176 | 59.328 | 37.407 |
Kosten van de omzet
| 40.189 | 41.278 | 34.438 | 28.537 | 22.853 | 28.518 | 14.086 | 11.555 | 13.104 | 9.732 | 7.374 | 7.559 | 6.472 | 5.689 | 4.529 |
Brutowinst
| 808.001 | 854.739 | 773.254 | 607.671 | 616.5 | 472.227 | 371.491 | 300.53 | 254.002 | 229.779 | 186.235 | 139.958 | 96.704 | 53.638 | 32.878 |
Brutowinstmarge
| 0.953 | 0.954 | 0.957 | 0.955 | 0.964 | 0.943 | 0.963 | 0.963 | 0.951 | 0.959 | 0.962 | 0.949 | 0.937 | 0.904 | 0.879 |
Onderzoek- en ontwikkelingskosten
| 112.196 | 106.019 | 87.927 | 64.875 | 41.171 | 13.479 | 7.702 | 9.237 | 10.301 | 10.997 | 10.088 | 5.771 | 3.818 | 3.924 | 0 |
Algemene en administratieve kosten
| 9.264 | 5.575 | 8.684 | 7.501 | 8.136 | 8.84 | 8.609 | 5.557 | 5.277 | 10.47 | 4.663 | 7.698 | 5.547 | 3.841 | 7.427 |
Verkoop- en marketingkosten
| 323.167 | 311.811 | 282.108 | 223.655 | 223.702 | 168.288 | 128.888 | 114.497 | 96.044 | 88.691 | 75.726 | 55.934 | 37.799 | 23.321 | 18.432 |
Verkoop-, algemene en administratieve kosten
| 332.431 | 317.386 | 290.793 | 231.156 | 231.838 | 177.128 | 137.497 | 120.054 | 101.322 | 99.161 | 80.39 | 63.631 | 43.346 | 27.163 | 25.859 |
Overige kosten
| 0.982 | 16.079 | 28.472 | 16.935 | 25.186 | 1.627 | 2.746 | 0.372 | 4.529 | 6.512 | 1.46 | 3.045 | 2.76 | 2.07 | 0.028 |
Bedrijfskosten
| 494.185 | 439.484 | 407.192 | 312.965 | 298.195 | 218.648 | 164.452 | 150.537 | 125.316 | 121.962 | 104.387 | 78.765 | 54.339 | 35.745 | 25.941 |
Bedrijfsresultaat
| 344.973 | 396.207 | 392.905 | 321.518 | 343.375 | 271.356 | 216.223 | 155.966 | 134.123 | 112.41 | 81.692 | 60.36 | 41.175 | 18.636 | 9.779 |
Bedrijfsresultaat ratio
| 0.407 | 0.442 | 0.486 | 0.505 | 0.537 | 0.542 | 0.561 | 0.5 | 0.502 | 0.469 | 0.422 | 0.409 | 0.399 | 0.314 | 0.261 |
Totaal overige inkomsten en kosten netto
| 0.982 | 2.54 | 0.092 | 1.098 | 2.341 | 19.404 | 11.93 | 1.839 | 9.931 | 11.061 | 1.262 | 2.21 | 1.568 | 2.793 | 2.868 |
Inkomen voor belasting
| 345.956 | 398.747 | 392.998 | 322.616 | 345.716 | 272.982 | 218.969 | 151.832 | 138.616 | 118.878 | 83.111 | 63.403 | 43.934 | 20.686 | 9.805 |
Inkomen voor belasting ratio
| 0.408 | 0.445 | 0.487 | 0.507 | 0.541 | 0.545 | 0.568 | 0.487 | 0.519 | 0.496 | 0.429 | 0.43 | 0.426 | 0.349 | 0.262 |
Belastingkosten
| 50.433 | 63.022 | 66.709 | 52.892 | 53.096 | 41.118 | 32.865 | 22.631 | 20.8 | 19.33 | 12.56 | 9.633 | 6.669 | 2.281 | -0.708 |
Nettowinst
| 310.185 | 348.773 | 337.991 | 278.447 | 298.297 | 232.884 | 186.104 | 129.201 | 117.82 | 99.555 | 70.564 | 53.774 | 37.265 | 18.406 | 10.513 |
Nettowinstmarge
| 0.366 | 0.389 | 0.418 | 0.438 | 0.467 | 0.465 | 0.483 | 0.414 | 0.441 | 0.416 | 0.364 | 0.365 | 0.361 | 0.31 | 0.281 |
WPA (Winst Per Aandeel)
| 0.59 | 0.67 | 0.65 | 0.53 | 0.57 | 0.44 | 0.36 | 0.25 | 0.23 | 0.19 | 0.15 | 0.12 | 0.079 | 0.041 | 0.016 |
Verwaterde WPA
| 0.59 | 0.67 | 0.65 | 0.53 | 0.57 | 0.44 | 0.36 | 0.25 | 0.23 | 0.19 | 0.15 | 0.12 | 0.079 | 0.041 | 0.016 |
EBITDA
| 385.956 | 472.119 | 420.121 | 307.44 | 329.656 | 262.036 | 215.411 | 162.039 | 134.187 | 112.846 | 87.81 | 67.982 | 48.563 | 23.491 | 8.553 |
EBITDA ratio
| 0.455 | 0.527 | 0.52 | 0.483 | 0.516 | 0.523 | 0.559 | 0.519 | 0.502 | 0.471 | 0.454 | 0.461 | 0.471 | 0.396 | 0.229 |